Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9774)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 15, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kang BW, Kim JG, Lee IH, Bae HI, Seo AN. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol 2017; 9(7): 293-299 [PMID: 28808502 DOI: 10.4251/wjgo.v9.i7.293] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i7/293.htm |
| Number | Citing Articles |
| 1 |
Daniela Cornelia Lazăr, Mihaela Flavia Avram, Ioan Romoșan, Mărioara Cornianu, Sorina Tăban, Adrian Goldiș. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World Journal of Gastroenterology 2018; 24(32): 3583-3616 doi: 10.3748/wjg.v24.i32.3583
|
| 2 |
Jun Lu, Yu Xu, Yuan Wu, Xiao-yan Huang, Jian-wei Xie, Jia-bin Wang, Jian-xian Lin, Ping Li, Chao-hui Zheng, Ai-min Huang, Chang-ming Huang. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6089-z
|
| 3 |
Chen Zhong, Zongchang Song, Min Li. Gastric cancer patients display a distinctive population of IFNg+IL10+ double positive CD8 T cells, which persists longer during prolonged activation. Experimental Cell Research 2019; 382(2): 111487 doi: 10.1016/j.yexcr.2019.06.032
|
| 4 |
Virginia Arrazubi, Maria Alsina. Immune Strategies for Gastrointestinal Cancer. Cancer Immunotherapy 2021; 2: 59 doi: 10.1007/13905_2021_3
|
| 5 |
Zhaoxiong Zhang, Wenxin Zhang, Xin Liu, Yongjia Yan, Weihua Fu. T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14670
|
| 6 |
Yoonjin Kwak, Soo Kyung Nam, Yujun Park, Yun-Suhk Suh, Sang-Hoon Ahn, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Hyung-Ho Kim, Han-Kwang Yang, Hye Seung Lee. Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma. Modern Pathology 2024; 37(10): 100568 doi: 10.1016/j.modpat.2024.100568
|
| 7 |
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri, Narges Soozangar. Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based Vaccination. Immunotherapy 2022; 14(6): 475 doi: 10.2217/imt-2021-0285
|
| 8 |
Weiqun Lu, Wei Wu, Xiaolong Wang, Zhuo Lv, Yongjun Han, Lili Wei, Liping Li, Gang Ji. Investigation of two ferroptosis-related molecular subtypes and biomarkers in the progression of gastric adenocarcinoma. All Life 2022; 15(1): 537 doi: 10.1080/26895293.2022.2066196
|
| 9 |
Smita S Joshi, Steven B Maron, Daniel V Catenacci. Pembrolizumab for Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. Future Oncology 2018; 14(5): 417 doi: 10.2217/fon-2017-0436
|
| 10 |
Bei Ji, Lili Qiao, Wei Zhai. CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer. Digestive Diseases and Sciences 2023; 68(3): 791 doi: 10.1007/s10620-022-07513-9
|
| 11 |
Toshiaki Morihiro, Shinji Kuroda, Nobuhiko Kanaya, Yoshihiko Kakiuchi, Tetsushi Kubota, Katsuyuki Aoyama, Takehiro Tanaka, Satoru Kikuchi, Takeshi Nagasaka, Masahiko Nishizaki, Shunsuke Kagawa, Hiroshi Tazawa, Toshiyoshi Fujiwara. PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41177-2
|
| 12 |
C. Coutzac, S. Pernot, N. Chaput, A. Zaanan. Immunotherapy in advanced gastric cancer, is it the future?. Critical Reviews in Oncology/Hematology 2019; 133: 25 doi: 10.1016/j.critrevonc.2018.10.007
|
| 13 |
Pegah Mousavi, Ali Ahmadi, Shakila Behzadifar, Javad Mohammadnejad, Seyed Mohammad Hosseini. Gastric Cancer - Progress and Challenges in the Era of Precision Medicine. 2024; doi: 10.5772/intechopen.1005783
|
| 14 |
Chen Zeng, Ran Yan, Guanghua Yang, Sen Xiang, Fuli Zhao. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial–mesenchymal transition of gastric cancer cells. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193181
|
| 15 |
Evita Gasenko, Sergejs Isajevs, Maria Constanza Camargo, George Johan A. Offerhaus, Inese Polaka, Margaret L. Gulley, Roberts Skapars, Armands Sivins, Ilona Kojalo, Arnis Kirsners, Daiga Santare, Jelizaveta Pavlova, Olga Sjomina, Elina Liepina, Liliana Tzivian, Charles S. Rabkin, Marcis Leja. Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia. European Journal of Gastroenterology & Hepatology 2019; 31(11): 1328 doi: 10.1097/MEG.0000000000001521
|
| 16 |
Rilan Bai, Naifei Chen, Tingting Liang, Lingyu Li, Zheng Lv, Xiaomin Lv, Jiuwei Cui. Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00912
|
| 17 |
Zhu Zeng, Biao Yang, Zhengyin Liao. Progress and Prospects of Immune Checkpoint Inhibitors in Advanced Gastric Cancer. Future Oncology 2021; 17(12): 1553 doi: 10.2217/fon-2020-0829
|
| 18 |
Sumi Yun, Jiwon Koh, Soo Kyung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Joong Do Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy. Cancer Immunology, Immunotherapy 2021; 70(2): 431 doi: 10.1007/s00262-020-02694-6
|
| 19 |
Karim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, Stefano Brocchi, Giovanni Marasco, Luigi Vincenzo Pastore, Fabiola Lorena Rojas Llimpe, Rita Golfieri, Matteo Renzulli. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. International Journal of Molecular Sciences 2021; 22(8): 3805 doi: 10.3390/ijms22083805
|
| 20 |
Xinyue Li, Jing Yang. Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02507-3
|
| 21 |
Ethem Ömeroğlu. The relationship between URG4 and clinicopathologic parameters and its effect on two-year survival in gastric carcinoma. Translational Oncology 2024; 50: 102122 doi: 10.1016/j.tranon.2024.102122
|
| 22 |
José Dario Portillo-Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral. mRNA vaccines in gastric cancer: How close are we?. Vacunas 2024; 25(1): 88 doi: 10.1016/j.vacun.2023.10.006
|
| 23 |
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, Peter Thuss-Patience, Sylvie Lorenzen, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Thomas Ettrich, Udo Lindig, Lutz Jacobasch, Daniel Pink, Salah-Eddin Al-Batran, Axel Hinke, Susanna Hegewisch-Becker, Sven Nilsson, Carsten Bokemeyer, Alexander Stein. Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217). BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06958-3
|
| 24 |
Se Jun Park, Jinsoo Lee, Hyunho Kim, Kabsoo Shin, MyungAh Lee, Jae Myung Park, Myung-Gyu Choi, Cho Hyun Park, Kyo Young Song, Han Hong Lee, In-Ho Kim. Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer. The Korean Journal of Internal Medicine 2021; 36(3): 679 doi: 10.3904/kjim.2019.358
|
| 25 |
Riccardo Dolcetti, Valli De Re. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 189 doi: 10.1007/978-3-030-04861-7_12
|
| 26 |
Mengsha Tong, Chunyu Yu, Jinwen Shi, Wenwen Huang, Sai Ge, Mingwei Liu, Lei Song, Dongdong Zhan, Xia Xia, Wanlin Liu, Jinwen Feng, Wenhao Shi, Jiafu Ji, Jing Gao, Tieliu Shi, Weimin Zhu, Chen Ding, Yi Wang, Fuchu He, Lin Shen, Tingting Li, Jun Qin. Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer. iScience 2019; 22: 44 doi: 10.1016/j.isci.2019.11.003
|
| 27 |
Yizhen Chen, Yifan Chen, Song Tan, Yuanyuan Zheng, Shaolin Liu, Tao Zheng, Yulong Mi, Shentao Lin, Changshun Yang, Weihua Li. Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022. Human Vaccines & Immunotherapeutics 2023; 19(1) doi: 10.1080/21645515.2023.2186684
|
| 28 |
Naziha Mansuri, Eva-Maria Birkman, Vanina D. Heuser, Minnamaija Lintunen, Annika Ålgars, Jari Sundström, Raija Ristamäki, Laura Lehtinen, Olli Carpén. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Archiv 2021; 478(4): 707 doi: 10.1007/s00428-020-02932-3
|
| 29 |
Yoon Ju Jung, So Jung Kim, Ho Seok Seo, Han Hong Lee, Kyo Young Song, Sung Geun Kim. Low Absolute Lymphocyte Count Correlates with Lymph Node Metastases and Worse Survival of Patients with Gastric Cancer. Annals of Surgical Oncology 2024; 31(10): 6951 doi: 10.1245/s10434-024-15874-w
|
| 30 |
Shuang Dai, Tao Liu, Xiao-Qin Liu, Xiao-Ying Li, Ke Xu, Tao Ren, Feng Luo. Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.687473
|
| 31 |
Peng Zhao, Fei Lan, Hui Zhang, Guangwei Zeng, Dong Liu. Down‐regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1‐MMP. Clinical and Experimental Pharmacology and Physiology 2018; 45(10): 1010 doi: 10.1111/1440-1681.12974
|
| 32 |
Xiao-Jing Shi, Yongjun Wei, Boyang Ji. Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00203
|
| 33 |
Guanghui Zhao, Ning Liu, Shasha Wang, Jing Guo, Xiaoxu Song, Yaoyue Qi, Wensheng Qiu, Jing Lv. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Medicine 2020; 99(10): e19405 doi: 10.1097/MD.0000000000019405
|
| 34 |
Simon Pernot, Magali Terme, Nina Radosevic-Robin, Florence Castan, Cécile Badoual, Elie Marcheteau, Fréderique Penault-Llorca, Olivier Bouche, Jaafar Bennouna, Eric Francois, Francois Ghiringhelli, Christelle De La Fouchardiere, Emmanuelle Samalin, Jean Baptiste Bachet, Christophe Borg, Valérie Boige, Thibault Voron, Trevor Stanbury, Eric Tartour, Sophie Gourgou, David Malka, Julien Taieb. Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance. Gastric Cancer 2020; 23(1): 73 doi: 10.1007/s10120-019-00983-3
|
| 35 |
Linhai Li, Yiming Ouyang, Wenrong Wang, Dezhi Hou, Yu Zhu. The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer. PeerJ 2019; 7: e7993 doi: 10.7717/peerj.7993
|
| 36 |
Fangfang Chen, Jingping Yuan, Honglin Yan, Huan Liu, Shuai Yin. Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/6832867
|
| 37 |
M. Schoemmel, H. Loeser, M. Kraemer, S. Wagener-Ryczek, A. Hillmer, C. Bruns, M. Thelen, W. Schröder, T. Zander, A. Lechner, R. Buettner, H. Schlösser, F. Gebauer, A. Quaas, H. Loeser, T. Zander, F. Gebauer, A. Quaas. Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus. Clinical and Translational Oncology 2021; 23(8): 1601 doi: 10.1007/s12094-021-02556-2
|
| 38 |
Yuting Pan, Yue Ma, Guanghai Dai. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy. Nutrients 2023; 15(19): 4290 doi: 10.3390/nu15194290
|
| 39 |
Alessandro Agnarelli, Viviana Vella, Mark Samuels, Panagiotis Papanastasopoulos, Georgios Giamas. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022; 14(18): 4378 doi: 10.3390/cancers14184378
|
| 40 |
Aysen Yavuz, Kubra Simsek, Anil Alpsoy, Busra Altunay, Elif Ocak Gedik, Betul Unal, Cumhur Ibrahim Bassorgun, Ali Murat Tatli, Gulsum Ozlem Elpek. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma. World Journal of Gastrointestinal Pathophysiology 2024; 15(1): 91237 doi: 10.4291/wjgp.v15.i1.91237
|
| 41 |
Xianzhe Yu, Shan He, Jian Shen, Qiushi Huang, Peng Yang, Lin Huang, Dan Pu, Li Wang, Lu Li, Jinghua Liu, Zelong Liu, Lingling Zhu. Tumor vessel normalization and immunotherapy in gastric cancer. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221110176
|
| 42 |
Jun Xie, Liping Fu, Li Jin. Immunotherapy of gastric cancer: Past, future perspective and challenges. Pathology - Research and Practice 2021; 218: 153322 doi: 10.1016/j.prp.2020.153322
|
| 43 |
Shiquan Li, Nan Zhang, Yongping Yang, Tongjun Liu. Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells. Translational Oncology 2024; 40: 101842 doi: 10.1016/j.tranon.2023.101842
|
| 44 |
Enoch Kang, Sung Cheol Jung, Soo Kyung Nam, Yujun Park, Soo Hyun Seo, Kyoung Un Park, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee. Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06192-w
|
| 45 |
Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?. International Journal of Molecular Sciences 2018; 19(6): 1602 doi: 10.3390/ijms19061602
|
| 46 |
Wei-Ming Chen, Jing-Lan Liu, Huei-Chieh Chuang, Yong-Lin Chang, Chia-Ming Yeh, Cheng-Shyong Wu, Shu-Fen Wu. Helios Expression in Tumor-Infiltrating Lymphocytes Correlates with Overall Survival of Advanced Gastric Cancer Patients. Life 2020; 10(9): 189 doi: 10.3390/life10090189
|
| 47 |
José Dario Portillo-Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral. mRNA vaccines in gastric cancer: How close are we?. Vacunas (English Edition) 2024; 25(1): 88 doi: 10.1016/j.vacune.2024.02.012
|
| 48 |
Abhineet Uppal, Ahmed Dehal, Shu-Ching Chang, Dany Barrak, Yalda Naeini, John R. Jalas, Anton J. Bilchik. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. Journal of Gastrointestinal Surgery 2020; 24(1): 28 doi: 10.1007/s11605-019-04403-w
|
| 49 |
Feng Yang, Yun Bao, Zhongwen Zhou, Chen Jin, Deliang Fu. Preoperative neutrophil‐to‐lymphocyte ratio predicts malignancy and recurrence‐free survival of solid pseudopapillary tumor of the pancreas. Journal of Surgical Oncology 2019; 120(2): 241 doi: 10.1002/jso.25484
|
| 50 |
Shuang Ma, Fei Chen. Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors. Pathology - Research and Practice 2022; 238: 154110 doi: 10.1016/j.prp.2022.154110
|